Urology. 2009 Jun;73(6):1311-2. doi: 10.1016/j.urology.2009.01.028.

Editorial comment. The goals of minimizing resource use and treatment burden must be weighed against the risks of tumor progression and compromised cancer-specific outcomes.

Meng MV.

Source

University of California, San Francisco, School of Medicine, San Francisco, California, USA.

Comment on

Safety of active surveillance program for recurrent nonmuscle-invasive bladder carcinoma. [Urology. 2009]
Safety of active surveillance program for recurrent nonmuscle-invasive bladder carcinoma.Hernández V, Alvarez M, de la Peña E, Amaruch N, Martín MD, de la Morena JM, Gómez V, Llorente C. Urology. 2009 Jun; 73(6):1306-10. Epub 2009 Apr 18.

PMID:: 19482152; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Comment

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Bladder Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer. [Eur Urol. 2008]
Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.
Bubendorf L. Eur Urol. 2008 Aug; 54(2):407-8. Epub 2007 Dec 7.
Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer. [Eur Urol. 2008]
Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.
Pycha A. Eur Urol. 2008 Aug; 54(2):408. Epub 2007 Dec 7.
Editorial comment. [Urology. 2009]
Editorial comment.
Herr HW. Urology. 2009 Jul; 74(1):166.
Review Candidate quality of care indicators for localized bladder cancer. [Urol Oncol. 2009]
Review Candidate quality of care indicators for localized bladder cancer.
Cooperberg MR, Porter MP, Konety BR. Urol Oncol. 2009 Jul-Aug; 27(4):435-42.
Review Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer. [Expert Rev Anticancer Ther. 2009]
Review Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.
Clark PE. Expert Rev Anticancer Ther. 2009 Jun; 9(6):821-30.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Editorial comment. The goals of minimizing resource use and treatment burden mus...
Editorial comment. The goals of minimizing resource use and treatment burden must be weighed against the risks of tumor progression and compromised cancer-specific outcomes.
Urology. 2009 Jun ;73(6):1311-2. doi: 10.1016/j.urology.2009.01.028.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: